Compass Therapeutics, Inc.
CMPX
$1.97
$0.105.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.91M | 4.32M | 2.99M | 4.65M | 4.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.30M | 17.99M | 15.82M | 21.07M | 17.97M |
| Operating Income | -20.30M | -17.99M | -15.82M | -21.07M | -17.97M |
| Income Before Tax | -18.32M | -15.72M | -14.26M | -19.88M | -16.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.32M | -15.72M | -14.26M | -19.88M | -16.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.32M | -15.72M | -14.26M | -19.88M | -16.63M |
| EBIT | -20.30M | -17.99M | -15.82M | -21.07M | -17.97M |
| EBITDA | -20.28M | -17.97M | -15.80M | -20.97M | -17.83M |
| EPS Basic | -0.10 | -0.09 | -0.08 | -0.14 | -0.12 |
| Normalized Basic EPS | -0.06 | -0.05 | -0.05 | -0.09 | -0.08 |
| EPS Diluted | -0.10 | -0.09 | -0.08 | -0.14 | -0.12 |
| Normalized Diluted EPS | -0.06 | -0.05 | -0.05 | -0.09 | -0.08 |
| Average Basic Shares Outstanding | 186.40M | 184.84M | 168.78M | 138.28M | 138.24M |
| Average Diluted Shares Outstanding | 186.40M | 184.84M | 168.78M | 138.28M | 138.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |